Cryoport Systems appoints Chris LaGullo as Chief Operations Officer
Chris LaGullo, previously Chief Operating Officer at Unimed and Vice President, Americas at Marken, brings more than 30 years of experience spanning Unimed, Marken, Teva Pharmaceuticals, Merck, ConvaTec, Bristol-Myers Squibb and Philips. He is tasked with leadership of Cryoport Systems' global centers and BioServices operations, supporting an integrated end-to-end offering for the life-sciences sector. The announcement date is October 26, 2026, not November 2.
In advanced-therapy supply chains, where a cold-chain failure can irreversibly compromise a sometimes patient-specific treatment, concentrating end-to-end operational responsibility in a clearly identified COO is a governance choice, not just an organizational change. Its value depends on authority across storage, transport and BioServices handoffs; the failure mode is fragmented escalation when a temperature excursion puts a shipment at risk.